Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 1
Rischio genetico e meccanismi cerebrali di psicosi
Alessandro Bertolino, M.D., Ph.D.
Group of Psychiatric Neuroscience
Department of Psychiatry
Department of Basic Medical Science, Neuroscience and Sense Organs
University of Bari, ‘Aldo Moro’,
Italy
Outline
•The categorical diagnosis
•Beyond categorization: the Spectrum and the Research Domain Criteria
(RDoC) dimensions
2
•The etiology
•Conclusions
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 2
Outline
•The categorical diagnosis
•Beyond categorization: the Spectrum and the Research Domain Criteria
(RDoC) dimensions
3
•The etiology
•Conclusions
The history of Schizophrenia
Emil Kraepelin: dementia praecox and manic‐depression
Bleuler: the four A’s (affect, ambivalence, autism, thought association)
Schneider: first‐rank symptoms
Rosenhan’s pseudopatients and reliability of diagnosis
4
DSM III: the reification of symptoms
Crow and Andreasen
DSM V
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 3
Early identification: Ultra High Risk criteria
Between the ages of 15 and 30, these criteria identify three UHR groups based on intensity, frequency and duration of symptoms,
1. APS, attenuated psychotic symptoms
2. BLIPS, brief limited intermittent psychotic symptoms
3. Genetic vulnerability together with significant decline of functioning from baseline (TSRF, trait and state risk factors) and non‐specific prodromal symptoms (UPS).
Attempts at diagnosis of Bipolar Disorder
• Hippocrates – Melancholia and Mania
• Falret and Baillarger 1851 – Folie Circulaire
• Khalbaum and Krepelin – Manic depressive insanity
• DSM‐I, 1952: Manic Depressive Reactions
• DSM II 1968: Manic Depressive Illness• DSM‐II, 1968: Manic‐Depressive Illness
• DSM‐III, 1980: Manic Episode and Bipolar Disorder
• DSM‐IV, 1994: Bipolar Disorder and a Mixed Episode
• DSM‐5, 2013
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 4
Limitations of present diagnostic categorization
• No pathognomonic symptoms
• Heterogenity of clinical presentation
• No biological validity or validation
• Overlap between different categories
Outline
•The diagnosis of Bipolar Disorder
•Beyond categorization: the Spectrum and the Research Domain Criteria
(RDoC) dimensions
8
•The etiology
•Conclusions
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 5
Categories vs dimensions
• DSM – sharp definition of boundaries between categories
• The Bipolar Spectrum: mood and temperament are in a continuum within which the emotions of sadness and happiness can wax and wane shifting from physiology to pathology. The bipolar spectrum model suggests that several patient presentations not currently recognized by the DSM warrant consideration as part of a mood disorders continuum. These include hypomania or mania associated with antidepressants; manic symptoms which fall short of the current DSM threshold for hypomania; and depression attended by multiple non‐manic markers that are associated with bipolar course.
Evidence supporting the Spectrum concept
• no sharp boundaries exist between mania or depressiond l iand normal experience;
• current understanding about risk factors for bipolardisorder – non specific, additive and complex
• the diathesis‐stress model and the role of temperament;
• mounting empiric evidence from epidemiologic and clinical studies that spectrum presentations of bipolardisorder exist, fall along a continuum, and are oftenassociated with profound impairment.
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 6
Why have the Research Domain Criteria been generated?
• An increasingly comprehensive body of research in genetics• An increasingly comprehensive body of research in genetics, neuroscience, and behavioral science has transformed our understanding of how the brain produces adaptive behavior and its disruption.
• However, new findings on mental disorders have had limited li i l i t tl b th l d t l tclinical impact, partly because they map only moderately onto current diagnostic categories for mental illness.
• RDoC represents the beginning of a long‐term project to allow neuroscience‐based classification.
Research Domain Criteria (RDoC)
The objective of RDoC is to foster research to validate dimensions defined by neurobiology and behavioral measures that cut across current disorder gycategories, and that can inform future revisions of our diagnostic systems.
For a dimension to be included, evidence was needed
a) for the dimension to be a validated behavioral function;
b) for a neural circuit or system to play a preponderant role in implementing ) y p y p p p gthe function.
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 7
The RDoC matrix ‐ Domains, constructs and units of analysis
RDoC: Domains and constructsPositive Valence Systems
1. Approach motivation2. Initial responsiveness to reward attainment 3. Sustained/Longer‐term responsiveness toreward attainment
Arousal and Regulatory Systems
1. Arousal2. Circadian Rhythms3. Sleep and wakefulness4 Default Mode Networkreward attainment
4. Reward Learning5. Habit
Negative Valence Systems
1. Responses to acute threat (Fear)2. Responses to potential harm (Anxiety)3. Responses to sustained threat4. Frustrative non‐reward
4. Default Mode Network
Cognitive Systems
1. Attention2. Perception3. Declarative Memory4. Language5. Cognitive Control6. Working Memory
5. LossSocial Processes
1. Affiliation and Attachment2. Social Communication3. Perception and Understanding of Self4. Perception and Understanding of Others
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 8
Constructs and circuitsCircuits represent the core aspect of RDoC because they are central to all levels of biology
1.Negative Valence – Threat (e.g.,
Amygdala, Sub-genual Cingulate)
2.Positive Valence – Reward (e.g.,
Striatum, mesolimbic dopamine system)
3.Cognitive Systems/Working Memory –Dorsolateral Prefrontal Cortex
4.Systems for Social Processes - Facial expression recognition (e.g., ventral visual stream, fusiform gyrus)
5.Arousal/Regulatory processes -Readiness for stimulus processing and responding (e.g., brain resting state network)
Adapted from Meyer – Lindenberg and Weinberger, 2006
The phenotype of PFC dysfunction in Schizophrenia
Callicott et al. Am J Psychiatry 2003Callicott et al. Cerebral Cortex 2000
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 9
Neural dysfunction during emotion processing in BP
Phillips Am J Psychiatry 2014
Limitations of the RDoC approach
• Diagnosis may be as difficult as if using categorical approaches
• Oversimplification of psychopathology – amygdala reactivity and negativeOversimplification of psychopathology amygdala reactivity and negative valence, DLPFC reactivity and cognition
• No definition of disease
• Psychosis and Depression
• Longitudinal profile of change (TIME)
• Brain circuits in animal models do not fully reflect circuits of humansBrain circuits in animal models do not fully reflect circuits of humans
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 10
Outline
•The diagnosis of Bipolar Disorder
•Beyond categorization: the Spectrum and the Research Domain Criteria
(RDoC) dimensions
19
•The etiology
•Conclusions
Heritability of Psychiatric Disorders ‐ They are likely caused by a combination of common variants with small effect and highly
penetrant rare variants
Tsuji Human Mol Genetics 2010Sullivan et al Nature Reviews Genetics 2012
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 11
Signaling pathwaysThe D2 cAMP‐independent pathway includes some of the
usual suspects
Li and Jope, Neuropsychopharm 2010
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 12
Functional genetic variation within HTR2A, systems level phenotypes and response to treatment
Blasi et al., JAMA Psychiatry 2013
Interaction between DRD2 rs1076560 and Cannabis use on risk for Psychosis
Colizzi et al, Schizophrenia Bull 2015
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 13
Multiple variants of small effect contribute to risk for BPD
Purcell et al, Nature Genetics 2009
Genetic relationship between Schizophrenia and other Psychiatric Disorders
Lee et al, Nature Genetics 2013
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 14
La pleiotropia in psichiatriafunzione alterata di un gene che influenza diversi tratti
Antilla et al, BioRxiv 2017
Biological insights from 108 schizophrenia‐associated genetic loci
Up to 36,989 cases and 113,075 controls
>1.5 million genetic variables
DRD2
Ripke et al, Nature 2014
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 15
Genetics of Bipolar Disorder, the latest GWA iteration – 56 SNPs
Mühleisen et al. Nat Commun. 2014 Mar 11;5:3339.
ADCY2
Risk loci with shared effects on five major psychiatric disorders: GWA (Patients N=33k; Controls N 28k)
Smoller et al, Lancet 2013
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 16
Testing genetic association with neural activity supporting behavioral dimensions
Aims• Identify, with a data-driven approach, the brain regions under genetic control during emotionprocessing;• Identify single-nucleotide polymorphisms (SNPs) associated with activity in the brain areasunder genetic control.
With these aims:• In healthy twins, we located the areas whose functionality is mainly under genetic control;• In healthy non-twins we investigated the contribution of specific SNPs in explaining the varianceof those previously located areas.
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 17
Activity in Amygdala during emotion processing is highly heritable
Brain areas with the largest genetic component (ICC)z:
-22
ACE model0.540053 a2
0.396206 c2
0.06374 e2
ICC F p0.79936827 10.2497291 1.5688E-05
ICC and ACE model computation of combined left and right amygdala signals
x: -1
4, y
: 0, z
ICC=0.66 (p<0.001)
x: 2
4, y
: 0, z
: -18
ICC=0.83 (p<0.001)
a2=additive geneticsc2=common environmente2=unique environment
Quarto et al, in preparation
SimpleM = 0.05
One variant is associated with activity in Amygdala from GWAS
From the GWAS analysis, one SNP (rs1198575) survived the simpleM correction (Bonferroni correction based on the estimation of the number of effectively independent tests – Gao et al., 2008 Genetic Epidemiology) of p<0.05, with the C allele being associated with lower amygdala activity.
CC CT TT
Quarto et al, in preparation
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 18
rs1198575Chromosome 1:98562260
ENSEMBL v75 – Feb 2014ENSEMBL v75 Feb 2014
SNP is located in the 5´ region of the MIR137 host gene, at 51kbp from MIR137 and at 47kbp from the HG
rs1198575
rs1198575 is associated with risk for schizophrenia
The C allele of the rs1198575 has been associated with risk for schizophrenia in the genome-wide association study of the Psychiatric Genomics Consortium (Ripke et al., 2014 Nature).
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 19
DRD2Module as identified with WGCNADataset: Braincloud (Colantuoni et al. 2011, Nature)
hub genes DRD2 pathway related genes Network genes
Pergola, Di Carlo et al, Translational Psychiatry 2017
Rank Marker Gene Gene Name MAF
SNPs associated with expression of the whole DRD2 module
D2L coexpression genetic score
1 rs2486064 CHIT1 Chitinase 1 0,22
2 rs6902039 GPLD1 Glycosylphosphatidylinositol Specific Phospholipase D1 0,23
3 rs851436 OSR1 Odd‐Skipped Related 1 0,48
4 rs9297283 POP1 Processing Of Precursor 1, Ribonuclease P/MRP Subunit 0,20
5 rs12940715 SDK2 sidekick cell adhesion molecule 2 0,12
6 rs1805453 DHX33 DEAH (Asp‐Glu‐Ala‐His) Box Polypeptide 33 0,34
ll l i7 rs11213916 BTG4 B‐Cell Translocation Gene 4 0,30
8 rs1037791 AGR2 Anterior Gradient 2 0,31
Pergola, Di Carlo et al., Translational Psychiatry 2017
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 20
Genetic Score predicts brain activity during WMN=125, p < 0.05, corrected
N=244, p < 0.05, corrected
NSFG (BA 10)
Pergola et al, Transl Psychiatry, 2017
D2L PGS
SIGNALCHANGEIN
The association between treatment response and DRD2 PGS in schizophrenia (discovery and replication)
Rho=.39; p= .007 Rho= .27, p= .047
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 21
Bromocriptine changes the relationship between D2L genetic score and DLPFC activity only when GS is
considered as a quadratic term
D2L coexpression genetic score
Selvaggi, Pergola et al., submitted
Outline
•The diagnosis of Bipolar Disorder
•Beyond categorization: the Spectrum and the Research Domain Criteria
(RDoC) dimensions
42
•The etiology
•Conclusions
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 22
The purpose of diagnostic validity
• making a correct prognosis
• performing correct treatment
• making correct predictions of outcome
Acknowledgements
Lieber Institute for Brain Development, JHU, Baltimore, MD, USA
GNP – DSNP
University of Bari Italy
Gianluca UrsiniVenkata S Mattay
Daniel R Weinberger
Giuseppe Blasi, Grazia Caforio, Annabella Di Giorgio, Giulio
Pergola, Antonio Rampino
Ileana Andriola, Linda Antonucci, Mariateresa Attrotto, Lucia
Colagiorgio, Marco Colizzi, Enrico D’Ambrosio, Pasquale Di Carlo,
Leonardo Fazio, Barbara Gelao, Riccarda Lomuscio, Luisa Longo,
Marina Mancini, Rita Masellis, Maria Antonietta Nettis,
Apostolos Papazacharias, Vincenzo Pierro, Annamaria Porcelli,
Tiziana Quarto, Giuseppe Rizzo, Raffaella Romano, PierluigiGIPPsi/ASL BA
44
Tiziana Quarto, Giuseppe Rizzo, Raffaella Romano, Pierluigi
Selvaggi, Paolo Taurisano
Department of PsychiatryUniversity of Udine
Fabio Sambataro
Angela CarofiglioGiuseppe VerrastroDaria PortnovaCristina Filograno
Convegno Nazionale GISDI GISDAP Milano 11 – 13 maggio 2017
Responsabilità Professionale e Danno alla Persona in Psichiatria 23
Conclusions
• Integrating categorical and dimensional approaches improves the reliability of diagnosis
• Common genetic variation is shared between different psychiatric disorders
• The molecular convergence of genetic risk can also be g gidentified with dimensional phenotypes and co‐expression